Hypertension in women

Research output: Contribution to journalArticle

Abstract

Systolic blood pressure is higher in African American and Hispanic women older than 60 and in white women older than 70 than it is in men. Coupled with their longer survival, elderly women have higher hypertension prevalence rates, particularly for isolated systolic hypertension. Hemodynamic characteristics differ by sex for premenopausal women and age-matched men, but these differences lessen after menopause. This transition may result from hormonal or metabolic alterations, including weight gain and tissue adiposity, which are common after menopause. Clinical trials enrolling large numbers of women support the benefits of treatment to reduce cardiovascular events and mortality. The trend to enroll subjects with several comorbidities and thereby increase event rates may limit the applicability of trial results to healthier women. Women appear more prone to develop side effects from antihypertensive medications and may metabolize these agents differently. There is a need for additional studies regarding appropriate drug selection, dosage, and combination therapy for women.

Original languageEnglish (US)
Pages (from-to)239-244
Number of pages6
JournalCurrent Cardiovascular Risk Reports
Volume2
Issue number3
DOIs
StatePublished - 2008

Fingerprint

Hypertension
Menopause
Blood Pressure
Adiposity
Hispanic Americans
Sex Characteristics
African Americans
Antihypertensive Agents
Weight Gain
Comorbidity
Hemodynamics
Clinical Trials
Survival
Mortality
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Hypertension in women. / Taler, Sandra J.

In: Current Cardiovascular Risk Reports, Vol. 2, No. 3, 2008, p. 239-244.

Research output: Contribution to journalArticle

@article{27cb367c84544d96bdf82fc318c4aea8,
title = "Hypertension in women",
abstract = "Systolic blood pressure is higher in African American and Hispanic women older than 60 and in white women older than 70 than it is in men. Coupled with their longer survival, elderly women have higher hypertension prevalence rates, particularly for isolated systolic hypertension. Hemodynamic characteristics differ by sex for premenopausal women and age-matched men, but these differences lessen after menopause. This transition may result from hormonal or metabolic alterations, including weight gain and tissue adiposity, which are common after menopause. Clinical trials enrolling large numbers of women support the benefits of treatment to reduce cardiovascular events and mortality. The trend to enroll subjects with several comorbidities and thereby increase event rates may limit the applicability of trial results to healthier women. Women appear more prone to develop side effects from antihypertensive medications and may metabolize these agents differently. There is a need for additional studies regarding appropriate drug selection, dosage, and combination therapy for women.",
author = "Taler, {Sandra J}",
year = "2008",
doi = "10.1007/s12170-008-0044-x",
language = "English (US)",
volume = "2",
pages = "239--244",
journal = "Current Cardiovascular Risk Reports",
issn = "1932-9520",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Hypertension in women

AU - Taler, Sandra J

PY - 2008

Y1 - 2008

N2 - Systolic blood pressure is higher in African American and Hispanic women older than 60 and in white women older than 70 than it is in men. Coupled with their longer survival, elderly women have higher hypertension prevalence rates, particularly for isolated systolic hypertension. Hemodynamic characteristics differ by sex for premenopausal women and age-matched men, but these differences lessen after menopause. This transition may result from hormonal or metabolic alterations, including weight gain and tissue adiposity, which are common after menopause. Clinical trials enrolling large numbers of women support the benefits of treatment to reduce cardiovascular events and mortality. The trend to enroll subjects with several comorbidities and thereby increase event rates may limit the applicability of trial results to healthier women. Women appear more prone to develop side effects from antihypertensive medications and may metabolize these agents differently. There is a need for additional studies regarding appropriate drug selection, dosage, and combination therapy for women.

AB - Systolic blood pressure is higher in African American and Hispanic women older than 60 and in white women older than 70 than it is in men. Coupled with their longer survival, elderly women have higher hypertension prevalence rates, particularly for isolated systolic hypertension. Hemodynamic characteristics differ by sex for premenopausal women and age-matched men, but these differences lessen after menopause. This transition may result from hormonal or metabolic alterations, including weight gain and tissue adiposity, which are common after menopause. Clinical trials enrolling large numbers of women support the benefits of treatment to reduce cardiovascular events and mortality. The trend to enroll subjects with several comorbidities and thereby increase event rates may limit the applicability of trial results to healthier women. Women appear more prone to develop side effects from antihypertensive medications and may metabolize these agents differently. There is a need for additional studies regarding appropriate drug selection, dosage, and combination therapy for women.

UR - http://www.scopus.com/inward/record.url?scp=84873509943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873509943&partnerID=8YFLogxK

U2 - 10.1007/s12170-008-0044-x

DO - 10.1007/s12170-008-0044-x

M3 - Article

AN - SCOPUS:84873509943

VL - 2

SP - 239

EP - 244

JO - Current Cardiovascular Risk Reports

JF - Current Cardiovascular Risk Reports

SN - 1932-9520

IS - 3

ER -